Home » Topics » BioWorld

BioWorld
RSS

SYNERGEN CEO SAYS ANTRIL WILL COMPETE

Sep. 25, 1991

MERCK SEEKS NATURAL DRUG SOURCES

Sep. 25, 1991

ENROLLMENT BEGINS FOR AIDS TRIALS

Sep. 25, 1991

JOINT U.S./CANADIAN REVIEW OF DEPRENYL

Sep. 25, 1991

PHARMATEC TO RAISE $5.5 MILLION

Sep. 25, 1991

CELLPRO GROSSES $33 MILLION IN IPO

Sep. 25, 1991

GENENTECH TO CO-DEVELOP SEPSIS DRUG

Sep. 24, 1991

SYNERGEN LEADS BIOTECH STOCK SLIDE

Sep. 24, 1991

GENPHARM GETS RIGHTS TO TRANSGENIC MICE

Sep. 24, 1991

SALE OF CETUS' PCR PASSES HURDLE

Sep. 24, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...